IL155950A0 - Heterocyclic ether substituted imidazoquinolines - Google Patents

Heterocyclic ether substituted imidazoquinolines

Info

Publication number: IL155950A0
Authority: IL; Israel
Prior art keywords: ether substituted; heterocyclic ether; substituted imidazoquinolines; imidazoquinolines; heterocyclic
Prior art date: 2000-12-08

Application number

IL15595001A

Other languages

English (en)

Original Assignee

3M Innovative Properties Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-08

Filing date

2001-12-06

Publication date

2003-12-23

2001-12-06 Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co

2003-12-23 Publication of IL155950A0 publication Critical patent/IL155950A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
AIDS & HIV (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Transplantation (AREA)

IL15595001A 2000-12-08 2001-12-06 Heterocyclic ether substituted imidazoquinolines IL155950A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US25421800P	2000-12-08	2000-12-08
PCT/US2001/046704 WO2002046193A2 (en)	2000-12-08	2001-12-06	Heterocyclic ether substituted imidazoquinolines

Publications (1)

Publication Number	Publication Date
IL155950A0 true IL155950A0 (en)	2003-12-23

Family

ID=22963391

Family Applications (6)

Application Number	Title	Priority Date	Filing Date
IL15595001A IL155950A0 (en)	2000-12-08	2001-12-06	Heterocyclic ether substituted imidazoquinolines
IL15590301A IL155903A0 (en)	2000-12-08	2001-12-06	Urea substituted imidazoquinoline ethers
IL15604301A IL156043A0 (en)	2000-12-08	2001-12-06	Aryl ether substituted imidazoquinolines
IL15588401A IL155884A0 (en)	2000-12-08	2001-12-06	Sulfonamido ether substituted imidazoquinolines
IL15590401A IL155904A0 (en)	2000-12-08	2001-12-06	Thioether substituted imidazoquinolines
IL15604401A IL156044A0 (en)	2000-12-08	2001-12-06	Amido ether substituted imidazoquinolines

Family Applications After (5)

Application Number	Title	Priority Date	Filing Date
IL15590301A IL155903A0 (en)	2000-12-08	2001-12-06	Urea substituted imidazoquinoline ethers
IL15604301A IL156043A0 (en)	2000-12-08	2001-12-06	Aryl ether substituted imidazoquinolines
IL15588401A IL155884A0 (en)	2000-12-08	2001-12-06	Sulfonamido ether substituted imidazoquinolines
IL15590401A IL155904A0 (en)	2000-12-08	2001-12-06	Thioether substituted imidazoquinolines
IL15604401A IL156044A0 (en)	2000-12-08	2001-12-06	Amido ether substituted imidazoquinolines

Country Status (32)

Country	Link
US (8)	US6656938B2 (xx)
EP (6)	EP1341791B1 (xx)
JP (7)	JP2004521092A (xx)
KR (6)	KR20030070049A (xx)
CN (6)	CN1479739A (xx)
AR (6)	AR035669A1 (xx)
AT (3)	ATE296301T1 (xx)
AU (12)	AU3951602A (xx)
BR (6)	BR0116026A (xx)
CA (6)	CA2436983A1 (xx)
CY (2)	CY1105586T1 (xx)
CZ (6)	CZ20031561A3 (xx)
DE (3)	DE60117859T2 (xx)
DK (3)	DK1343784T3 (xx)
EE (6)	EE200300270A (xx)
ES (3)	ES2242782T3 (xx)
HK (3)	HK1064383A1 (xx)
HR (6)	HRP20030463A2 (xx)
HU (6)	HUP0600600A2 (xx)
IL (6)	IL155950A0 (xx)
MX (6)	MXPA03004975A (xx)
NO (6)	NO20032451L (xx)
NZ (6)	NZ526089A (xx)
PL (7)	PL361948A1 (xx)
PT (2)	PT1341791E (xx)
RU (6)	RU2003116063A (xx)
SI (1)	SI1341790T1 (xx)
SK (6)	SK7122003A3 (xx)
TW (3)	TWI222972B (xx)
UA (2)	UA74852C2 (xx)
WO (6)	WO2002046189A2 (xx)
ZA (6)	ZA200305274B (xx)

Families Citing this family (206)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5741908A (en)	1996-06-21	1998-04-21	Minnesota Mining And Manufacturing Company	Process for reparing imidazoquinolinamines
UA67760C2 (uk)	1997-12-11	2004-07-15	Міннесота Майнінг Енд Мануфакчурінг Компані	Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6756382B2 (en)	1999-06-10	2004-06-29	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6331539B1 (en)	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6541485B1 (en)	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6573273B1 (en)	1999-06-10	2003-06-03	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6916925B1 (en)	1999-11-05	2005-07-12	3M Innovative Properties Co.	Dye labeled imidazoquinoline compounds
JP3436512B2 (ja) *	1999-12-28	2003-08-11	株式会社デンソー	アクセル装置
US6660747B2 (en) *	2000-12-08	2003-12-09	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6664265B2 (en)	2000-12-08	2003-12-16	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6525064B1 (en)	2000-12-08	2003-02-25	3M Innovative Properties Company	Sulfonamido substituted imidazopyridines
UA74852C2 (en)	2000-12-08	2006-02-15	3M Innovative Properties Co	Urea-substituted imidazoquinoline ethers
US6545017B1 (en)	2000-12-08	2003-04-08	3M Innovative Properties Company	Urea substituted imidazopyridines
US6664264B2 (en) *	2000-12-08	2003-12-16	3M Innovative Properties Company	Thioether substituted imidazoquinolines
US6677347B2 (en) *	2000-12-08	2004-01-13	3M Innovative Properties Company	Sulfonamido ether substituted imidazoquinolines
US6677348B2 (en)	2000-12-08	2004-01-13	3M Innovative Properties Company	Aryl ether substituted imidazoquinolines
US6545016B1 (en)	2000-12-08	2003-04-08	3M Innovative Properties Company	Amide substituted imidazopyridines
US6660735B2 (en) *	2000-12-08	2003-12-09	3M Innovative Properties Company	Urea substituted imidazoquinoline ethers
US6667312B2 (en)	2000-12-08	2003-12-23	3M Innovative Properties Company	Thioether substituted imidazoquinolines
US7226928B2 (en) *	2001-06-15	2007-06-05	3M Innovative Properties Company	Methods for the treatment of periodontal disease
ES2312659T3 (es) *	2001-11-29	2009-03-01	3M Innovative Properties Company	Formulaciones farmaceuticas que comprenden un modificador de la respuesta inmune.
CA2365732A1 (en)	2001-12-20	2003-06-20	Ibm Canada Limited-Ibm Canada Limitee	Testing measurements
US6677349B1 (en)	2001-12-21	2004-01-13	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
IL147953A (en) *	2002-02-01	2008-04-13	Meir Bialer	Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
NZ534566A (en) *	2002-02-22	2007-02-23	3M Innovative Properties Co	Method of reducing and treating UVB-induced immunosuppression
GB0211649D0 (en) *	2002-05-21	2002-07-03	Novartis Ag	Organic compounds
CN1674894A (zh)	2002-06-07	2005-09-28	3M创新有限公司	醚取代的咪唑并吡啶
JP4903997B2 (ja) *	2002-07-02	2012-03-28	サザンリサーチインスティチュート	ＦｔｓＺの阻害剤およびそれらの用途
BR0313587A (pt) *	2002-08-15	2006-06-13	3M Innovative Properties Co	composições imunoestimuladoras e métodos de estimulação de uma resposta imune
WO2004028539A2 (en)	2002-09-26	2004-04-08	3M Innovative Properties Company	1h-imidazo dimers
NZ540826A (en) *	2002-12-20	2008-07-31	3M Innovative Properties Co	Aryl / hetaryl substituted imidazoquinolines
JP2006512391A (ja)	2002-12-30	2006-04-13	スリーエムイノベイティブプロパティズカンパニー	組み合わせ免疫賦活薬
US7375180B2 (en) *	2003-02-13	2008-05-20	3M Innovative Properties Company	Methods and compositions related to IRM compounds and Toll-like receptor 8
EP1599726A4 (en) *	2003-02-27	2009-07-22	3M Innovative Properties Co	SELECTIVE MODULATION OF TLR-MEDIATED BIOLOGICAL ACTIVITY
WO2004078138A2 (en)	2003-03-04	2004-09-16	3M Innovative Properties Company	Prophylactic treatment of uv-induced epidermal neoplasia
US7163947B2 (en) *	2003-03-07	2007-01-16	3M Innovative Properties Company	1-Amino 1H-imidazoquinolines
WO2004080398A2 (en) *	2003-03-07	2004-09-23	3M Innovative Properties Company	1-amino 1h-imidazoquinolines
AU2004220465A1 (en)	2003-03-13	2004-09-23	3M Innovative Properties Company	Method of tattoo removal
EP1608282A4 (en) *	2003-03-13	2010-12-08	3M Innovative Properties Co	METHODS OF DIAGNOSING SKIN LESIONS
NZ567227A (en) *	2003-03-13	2010-01-29	3M Innovative Properties Co	Methods of improving skin quality through topical application of an immune response modifier such as imiquimod
US20040192585A1 (en)	2003-03-25	2004-09-30	3M Innovative Properties Company	Treatment for basal cell carcinoma
AU2004244962A1 (en)	2003-04-10	2004-12-16	3M Innovative Properties Company	Delivery of immune response modifier compounds using metal-containing particulate support materials
US20040265351A1 (en)	2003-04-10	2004-12-30	Miller Richard L.	Methods and compositions for enhancing immune response
WO2004096144A2 (en) *	2003-04-28	2004-11-11	3M Innovative Properties Company	Compositions and methods for induction of opioid receptors
US20050032829A1 (en) *	2003-06-06	2005-02-10	3M Innovative Properties Company	Process for imidazo[4,5-c]pyridin-4-amines
US6943255B2 (en) *	2003-06-06	2005-09-13	3M Innovative Properties Company	Process for imidazo[4,5-c]pyridin-4-amines
EP1651216A2 (en) *	2003-08-05	2006-05-03	3M Innovative Properties Company	Infection prophylaxis using immune response modifier compounds
AR045260A1 (es) *	2003-08-12	2005-10-19	3M Innovative Properties Co	Compuestos que contienen imidazo-oxima sustituidos
JP4913593B2 (ja) *	2003-08-14	2012-04-11	スリーエムイノベイティブプロパティズカンパニー	脂質修飾された免疫応答調整剤
WO2005018555A2 (en) *	2003-08-14	2005-03-03	3M Innovative Properties Company	Lipid-modified immune response modifiers
WO2005020912A2 (en)	2003-08-25	2005-03-10	3M Innovative Properties Company	Delivery of immune response modifier compounds
US20050048072A1 (en) *	2003-08-25	2005-03-03	3M Innovative Properties Company	Immunostimulatory combinations and treatments
JP5128815B2 (ja) *	2003-08-27	2013-01-23	スリーエムイノベイティブプロパティズカンパニー	アリールオキシ置換およびアリールアルキレンオキシ置換イミダゾキノリン
CA2536578A1 (en) *	2003-09-02	2005-03-10	3M Innovative Properties Company	Methods related to the treatment of mucosal associated conditions
EP1660026A4 (en) *	2003-09-05	2008-07-16	3M Innovative Properties Co	TREATMENT FOR CD5 + B CELL LYMPHOMA
JP2007505629A (ja) *	2003-09-17	2007-03-15	スリーエムイノベイティブプロパティズカンパニー	Ｔｌｒ遺伝子発現の選択的調節
WO2005079195A2 (en)	2003-10-03	2005-09-01	3M Innovative Properties Company	Pyrazolopyridines and analogs thereof
US7544697B2 (en) *	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
EP1673087B1 (en)	2003-10-03	2015-05-13	3M Innovative Properties Company	Alkoxy substituted imidazoquinolines
US20090075980A1 (en) *	2003-10-03	2009-03-19	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and Analogs Thereof
JP2007509987A (ja) *	2003-10-31	2007-04-19	スリーエムイノベイティブプロパティズカンパニー	免疫応答調節剤化合物による好中球活性化
US8598192B2 (en)	2003-11-14	2013-12-03	3M Innovative Properties Company	Hydroxylamine substituted imidazoquinolines
CA2545774A1 (en) *	2003-11-14	2005-06-02	3M Innovative Properties Company	Oxime substituted imidazo ring compounds
AR046845A1 (es) *	2003-11-21	2005-12-28	Novartis Ag	Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas
CA2546117A1 (en) *	2003-11-21	2005-06-16	Novartis Ag	1h-imidazoquinoline derivatives as protein kinase inhibitors
WO2005051324A2 (en) *	2003-11-25	2005-06-09	3M Innovative Properties Company	Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
WO2005051317A2 (en)	2003-11-25	2005-06-09	3M Innovative Properties Company	Substituted imidazo ring systems and methods
US8940755B2 (en) *	2003-12-02	2015-01-27	3M Innovative Properties Company	Therapeutic combinations and methods including IRM compounds
CN1914203A (zh) *	2003-12-04	2007-02-14	3M创新有限公司	砜取代的咪唑环醚
EP1699792A1 (en) *	2003-12-29	2006-09-13	3M Innovative Properties Company	Piperazine, 1,4¨diazepane, 1,4¨diazocane, and 1,5¨diazocane fused imidazo ring compounds
JP2007517035A (ja)	2003-12-29	2007-06-28	スリーエムイノベイティブプロパティズカンパニー	アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
US20050158325A1 (en) *	2003-12-30	2005-07-21	3M Innovative Properties Company	Immunomodulatory combinations
JP2007517055A (ja) *	2003-12-30	2007-06-28	スリーエムイノベイティブプロパティズカンパニー	免疫応答の増強
WO2005066169A2 (en) *	2003-12-30	2005-07-21	3M Innovative Properties Company	Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
WO2005089317A2 (en)	2004-03-15	2005-09-29	3M Innovative Properties Company	Immune response modifier formulations and methods
AU2005228150A1 (en) *	2004-03-24	2005-10-13	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
EP1735010A4 (en) *	2004-04-09	2008-08-27	3M Innovative Properties Co	METHODS, COMPOSITIONS AND PREPARATIONS FOR ADMINISTRATION OF IMMUNE RESPONSE MODIFIERS (MRI)
US20050267145A1 (en) *	2004-05-28	2005-12-01	Merrill Bryon A	Treatment for lung cancer
WO2005123079A2 (en) *	2004-06-14	2005-12-29	3M Innovative Properties Company	Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) *	2004-06-15	2011-09-13	3M Innovative Properties Company	Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8541438B2 (en)	2004-06-18	2013-09-24	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
US7897609B2 (en)	2004-06-18	2011-03-01	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
US8026366B2 (en)	2004-06-18	2011-09-27	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006009832A1 (en) *	2004-06-18	2006-01-26	3M Innovative Properties Company	Substituted imidazo ring systems and methods
WO2006065280A2 (en)	2004-06-18	2006-06-22	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
EP1765348B1 (en) *	2004-06-18	2016-08-03	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
JP2008511683A (ja)	2004-09-02	2008-04-17	スリーエムイノベイティブプロパティズカンパニー	２−アミノ１ｈ−イミダゾ環構造および方法
US20090270443A1 (en) *	2004-09-02	2009-10-29	Doris Stoermer	1-amino imidazo-containing compounds and methods
CA2578741C (en) *	2004-09-02	2014-01-14	3M Innovative Properties Company	1-alkoxy 1h-imidazo ring systems and methods
WO2006029223A2 (en) *	2004-09-08	2006-03-16	Children's Medical Center Corporation	Method for stimulating the immune response of newborns
CN101824034A (zh) *	2004-09-14	2010-09-08	诺华疫苗和诊断公司	咪唑并喹啉化合物
US20070243215A1 (en) *	2004-10-08	2007-10-18	Miller Richard L	Adjuvant for Dna Vaccines
EP1819364A4 (en) *	2004-12-08	2010-12-29	3M Innovative Properties Co	COMPOSITIONS, IMMUNOMODULATORY COMBINATIONS AND ASSOCIATED METHODS
US8080560B2 (en) *	2004-12-17	2011-12-20	3M Innovative Properties Company	Immune response modifier formulations containing oleic acid and methods
JP5543068B2 (ja)	2004-12-30	2014-07-09	スリーエムイノベイティブプロパティズカンパニー	キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
CA2594674C (en)	2004-12-30	2016-05-17	3M Innovative Properties Company	Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
WO2006073939A2 (en) *	2004-12-30	2006-07-13	Takeda Pharmaceutical Company Limited	1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate
EP1830876B1 (en)	2004-12-30	2015-04-08	Meda AB	Use of imiquimod for the treatment of cutaneous metastases derived from a breast cancer tumor
US8436176B2 (en) *	2004-12-30	2013-05-07	Medicis Pharmaceutical Corporation	Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
US9248127B2 (en)	2005-02-04	2016-02-02	3M Innovative Properties Company	Aqueous gel formulations containing immune response modifiers
CA2602083A1 (en)	2005-02-09	2006-08-09	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods
WO2006086449A2 (en)	2005-02-09	2006-08-17	Coley Pharmaceutical Group, Inc.	Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
US8658666B2 (en)	2005-02-11	2014-02-25	3M Innovative Properties Company	Substituted imidazoquinolines and imidazonaphthyridines
AU2006213746A1 (en)	2005-02-11	2006-08-17	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
EP2298795A1 (en)	2005-02-18	2011-03-23	Novartis Vaccines and Diagnostics, Inc.	Immunogens from uropathogenic escherichia coli
HUE027400T2 (en)	2005-02-18	2016-10-28	Glaxosmithkline Biologicals Sa	Proteins and nucleic acids from meningitis / sepsis with Escherichia coli
CA2598639A1 (en)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazonaphthyridines
EP1851218A2 (en)	2005-02-23	2007-11-07	3M Innovative Properties Company	Hydroxyalkyl substituted imidazoquinoline compounds and methods
AU2006223634A1 (en)	2005-02-23	2006-09-21	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazoquinolines
JP2008538203A (ja)	2005-02-23	2008-10-16	コーリーファーマシューティカルグループ，インコーポレイテッド	インターフェロンの生合成を優先的に誘導する方法
RU2007137960A (ru)	2005-03-14	2009-04-20	Меда Аб (Se)	СПОСОБ ЛЕЧЕНИЯ АКТИНИЧЕСКОГО КЕРАТОЗА (ВАРИАНТЫ) И 2-МЕТИЛ-1-(2-МЕТИЛПРОПИЛ)-1Н-ИМИДАЗО[4,5-c]]1,5]НАФТИРИДИН-4-АМИН В КАЧЕСТВЕ СРЕДСТВА ЛЕЧЕНИЯ АКТИНИЧЕСКОГО КЕРАТОЗА
WO2006107851A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7943610B2 (en)	2005-04-01	2011-05-17	3M Innovative Properties Company	Pyrazolopyridine-1,4-diamines and analogs thereof
AU2006241166A1 (en) *	2005-04-25	2006-11-02	3M Innovative Properties Company	Immunostimulatory compositions
CA2615626A1 (en)	2005-07-18	2007-01-25	Novartis Ag	Small animal model for hcv replication
ZA200803029B (en)	2005-09-09	2009-02-25	Coley Pharm Group Inc	Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
AU2006287270A1 (en) *	2005-09-09	2007-03-15	Coley Pharmaceutical Group, Inc.	Amide and carbamate derivatives of N-{2-[4-amino-2- (ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods
US8889154B2 (en)	2005-09-15	2014-11-18	Medicis Pharmaceutical Corporation	Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
WO2007052055A1 (en)	2005-11-04	2007-05-10	Novartis Vaccines And Diagnostics Srl	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
JP2009514841A (ja)	2005-11-04	2009-04-09	ノバルティスヴァクシンズアンドダイアグノスティクスエスアールエル	粒子状アジュバントと免疫増強物質との組合せを含むインフルエンザワクチン
JP2009514850A (ja)	2005-11-04	2009-04-09	ノバルティスヴァクシンズアンドダイアグノスティクスエスアールエル	アジュバントとして減少した量の水中油型エマルションを有するインフルエンザワクチン
AU2006311871B2 (en)	2005-11-04	2011-03-03	3M Innovative Properties Company	Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods
JP2009514839A (ja)	2005-11-04	2009-04-09	ノバルティスヴァクシンズアンドダイアグノスティクスエスアールエル	サイトカイン誘導剤を含むアジュバントインフルエンザワクチン
PL2478916T3 (pl)	2006-01-27	2020-11-16	Seqirus UK Limited	Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy
US8951528B2 (en) *	2006-02-22	2015-02-10	3M Innovative Properties Company	Immune response modifier conjugates
WO2007106854A2 (en)	2006-03-15	2007-09-20	Coley Pharmaceutical Group, Inc.	Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods
US8173657B2 (en) *	2006-03-23	2012-05-08	Novartis Ag	Imidazoquinoxaline compounds as immunomodulators
CA2647100A1 (en) *	2006-03-23	2007-09-27	Novartis Ag	Methods for the preparation of imidazole-containing compounds
ES2388556T3 (es) *	2006-03-23	2012-10-16	Novartis Ag	Compuestos inmunopotenciadores
CA2646349A1 (en)	2006-03-24	2007-10-04	Novartis Vaccines And Diagnostics Gmbh & Co Kg	Storage of influenza vaccines without refrigeration
CA2647942A1 (en)	2006-03-31	2007-11-08	Novartis Ag	Combined mucosal and parenteral immunization against hiv
EP2054431B1 (en)	2006-06-09	2011-08-31	Novartis AG	Conformers of bacterial adhesins
WO2008008432A2 (en) *	2006-07-12	2008-01-17	Coley Pharmaceutical Group, Inc.	Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
JP2010500399A (ja)	2006-08-16	2010-01-07	ノバルティスアーゲー	尿路病原性大腸菌由来の免疫原
WO2008030511A2 (en)	2006-09-06	2008-03-13	Coley Pharmaceuticial Group, Inc.	Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes
US20100010199A1 (en)	2006-09-11	2010-01-14	Novartis Ag	Making influenza virus vaccines without using eggs
CA2671629C (en)	2006-12-06	2017-08-15	Novartis Ag	Vaccines including antigen from four strains of influenza virus
US20080149123A1 (en)	2006-12-22	2008-06-26	Mckay William D	Particulate material dispensing hairbrush with combination bristles
GB0700562D0 (en)	2007-01-11	2007-02-21	Novartis Vaccines & Diagnostic	Modified Saccharides
NZ582595A (en)	2007-06-27	2012-07-27	Novartis Ag	Low-additive influenza vaccines
GB0714963D0 (en)	2007-08-01	2007-09-12	Novartis Ag	Compositions comprising antigens
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
WO2009089900A1 (en) *	2008-01-15	2009-07-23	Meda Ab	Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives
PL2268618T3 (pl)	2008-03-03	2015-11-30	Novartis Ag	Związki i kompozycje jako modulatory aktywności receptorów TLR
JP5518041B2 (ja)	2008-03-18	2014-06-11	ノバルティスアーゲー	インフルエンザウイルスワクチン抗原の調製における改良
CN102438650A (zh)	2009-03-06	2012-05-02	诺华有限公司	衣原体抗原
AU2010229835B2 (en)	2009-03-25	2015-01-15	The Board Of Regents Of The University Of Texas System	Compositions for stimulation of mammalian innate immune resistance to pathogens
EP2510947B1 (en)	2009-04-14	2016-02-10	GlaxoSmithKline Biologicals SA	Compositions for immunising against Staphylococcus aureus
KR20120027276A (ko)	2009-04-27	2012-03-21	노파르티스 아게	인플루엔자를 예방하기 위한 면역증강된 백신
GB0907551D0 (en) *	2009-05-01	2009-06-10	Univ Dundee	Treatment or prophylaxis of proliferative conditions
AU2013203591B2 (en) *	2009-05-01	2017-01-19	University Court Of The University Of Dundee	Treatment or prophylaxis of proliferative conditions
CN102639147B (zh)	2009-07-15	2015-11-25	诺华股份有限公司	Rsv f 蛋白组合物和其制作方法
PL2464658T3 (pl)	2009-07-16	2015-03-31	Novartis Ag	Immunogeny z Escherichia coli o zniesionej toksyczności
GB0918392D0 (en)	2009-10-20	2009-12-02	Novartis Ag	Diagnostic and therapeutic methods
GB0919690D0 (en)	2009-11-10	2009-12-23	Guy S And St Thomas S Nhs Foun	compositions for immunising against staphylococcus aureus
GB201009861D0 (en)	2010-06-11	2010-07-21	Novartis Ag	OMV vaccines
CN103097386A (zh)	2010-08-17	2013-05-08	3M创新有限公司	脂质化免疫反应调节剂化合物的组合物、制剂及方法
ES2575688T3 (es)	2010-12-16	2016-06-30	Sumitomo Dainippon Pharma Co., Ltd.	Derivado de imidazo[4,5-c]quinolin-1-ilo útil en terapia
US10342862B2 (en)	2011-01-26	2019-07-09	Glaxosmithkline Biologicals, Sa	RSV immunization regimen
RS56748B1 (sr)	2011-05-13	2018-03-30	Glaxosmithkline Biologicals Sa	Pre-fuzioni rsv f antigeni
US8728486B2 (en)	2011-05-18	2014-05-20	University Of Kansas	Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
JP6460789B2 (ja)	2011-06-03	2019-01-30	スリーエムイノベイティブプロパティズカンパニー	ポリエチレングリコールセグメントを有するヘテロ２官能性リンカー及び該リンカーから調製された免疫反応調節複合体
JP6415979B2 (ja) *	2011-06-03	2018-10-31	スリーエムイノベイティブプロパティズカンパニー	ヒドラジノ１ｈ−イミダゾキノリン−４−アミン及びこれから調製された複合体
US20130023736A1 (en)	2011-07-21	2013-01-24	Stanley Dale Harpstead	Systems for drug delivery and monitoring
US9493517B2 (en)	2011-11-07	2016-11-15	Glaxosmithkline Biologicals Sa	Conjugates comprising an antigen and a carrier molecule
WO2013108272A2 (en)	2012-01-20	2013-07-25	International Centre For Genetic Engineering And Biotechnology	Blood stage malaria vaccine
CN112587658A (zh)	2012-07-18	2021-04-02	博笛生物科技有限公司	癌症的靶向免疫治疗
US20150335637A1 (en)	2013-01-07	2015-11-26	The Trustees Of The University Of Pennsylvania	Compositions and methods for treating cutaneous t cell lymphoma
US9919029B2 (en)	2013-07-26	2018-03-20	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of bacterial infections
CR20160214A (es)	2013-11-05	2016-10-11	3M Innovative Properties Co	Formulaciones de inyección con base en aceite de sésamo
EP2870974A1 (en)	2013-11-08	2015-05-13	Novartis AG	Salmonella conjugate vaccines
AU2015205753A1 (en)	2014-01-10	2016-07-21	Birdie Biopharmaceuticals Inc.	Compounds and compositions for treating HER2 positive tumors
RS59971B1 (sr)	2014-03-26	2020-03-31	Glaxosmithkline Biologicals Sa	Mutantni stafilokokni antigeni
JP6760919B2 (ja)	2014-07-09	2020-09-23	バーディーバイオファーマシューティカルズインコーポレイテッド	腫瘍を治療するための抗ｐｄ−ｌ１組み合わせ
CN112546231A (zh) *	2014-07-09	2021-03-26	博笛生物科技有限公司	用于治疗癌症的联合治疗组合物和联合治疗方法
CN105461767B (zh) *	2014-08-07	2019-03-12	富力	一种连翘苷的化学合成方法
CN112546238A (zh)	2014-09-01	2021-03-26	博笛生物科技有限公司	用于治疗肿瘤的抗-pd-l1结合物
US10286065B2 (en)	2014-09-19	2019-05-14	Board Of Regents, The University Of Texas System	Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
CN108137586B (zh) *	2015-09-14	2021-04-13	辉瑞大药厂	作为LRRK2抑制剂的新颖咪唑并[4,5-c]喹啉和咪唑并[4,5-c][1,5]萘啶衍生物
EP3356371A4 (en) *	2015-09-29	2020-06-24	The University of Chicago	POLYMER CONJUGATE VACCINE
WO2017059280A1 (en)	2015-10-02	2017-04-06	The University Of North Carolina At Chapel Hill	Novel pan-tam inhibitors and mer/axl dual inhibitors
CN106943596A (zh)	2016-01-07	2017-07-14	博笛生物科技（北京）有限公司	用于治疗肿瘤的抗-cd20组合
CN115252792A (zh)	2016-01-07	2022-11-01	博笛生物科技有限公司	用于治疗肿瘤的抗-egfr组合
CN115350279A (zh)	2016-01-07	2022-11-18	博笛生物科技有限公司	用于治疗肿瘤的抗-her2组合
MX2019005502A (es)	2016-11-09	2020-10-01	Univ Texas	Metodos y composiciones para inmunomodulacion adaptativa.
CN118515666A (zh)	2017-04-27	2024-08-20	博笛生物科技有限公司	2-氨基-喹啉衍生物
EP3641771A4 (en)	2017-06-23	2020-12-16	Birdie Biopharmaceuticals, Inc.	PHARMACEUTICAL COMPOSITIONS
CN111511740B (zh)	2017-12-20	2023-05-16	3M创新有限公司	用作免疫应答调节剂的带有支链连接基团的酰胺取代的咪唑并[4,5-c]喹啉化合物
CA3091027A1 (en)	2018-02-02	2019-08-08	Maverix Oncology, Inc.	Small molecule drug conjugates of gemcitabine monophosphate
MX2020008455A (es)	2018-02-28	2021-10-26	Pfizer	Variantes de il-15 y usos de las mismas.
CN111788202B (zh) *	2018-02-28	2024-03-01	3M创新有限公司	具有N-1支链基团的经取代的咪唑并[4,5-c]喹啉化合物
BR112020022595A2 (pt)	2018-05-23	2021-02-09	Pfizer Inc.	anticorpos específicos para gucy2c e usos dos mesmos
EP3797121B1 (en)	2018-05-23	2024-06-19	Pfizer Inc.	Antibodies specific for cd3 and uses thereof
CA3101277A1 (en) *	2018-05-24	2019-11-28	3M Innovative Properties Company	N-1 branched cycloalkyl substituted imidazo[4,5-c]quinoline compounds, compositions, and methods
CA3107305A1 (en) *	2018-07-24	2020-01-30	Torque Therapeutics, Inc.	Tlr7/8 agonists and liposome compositions
WO2020109898A1 (en) *	2018-11-26	2020-06-04	3M Innovative Properties Company	N-1 branched alkyl ether substituted imidazo[4,5-c]quinoline compounds, compositions, and methods
WO2020128893A1 (en)	2018-12-21	2020-06-25	Pfizer Inc.	Combination treatments of cancer comprising a tlr agonist
EP3921322A4 (en) *	2019-02-07	2022-07-20	Canwell Biotech Limited	PHOSPHORUS-IMIDAZOCHINOLINE-AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF
KR20210136014A (ko)	2019-02-12	2021-11-16	암브룩스, 인코포레이티드	항체-tlr 작용제 콘쥬게이트를 함유하는 조성물, 방법 및 이의 용도
KR20220091528A (ko)	2019-10-29	2022-06-30	프라임 리치 트레이딩 리미티드	4-아미노-이미다조퀴놀린 화합물 및 이의 용도
WO2021116420A1 (en)	2019-12-13	2021-06-17	INSERM (Institut National de la Santé et de la Recherche Médicale)	Use of tlr7 and/or tlr8 agonists for the treatment of leptospirosis
CN115397853A (zh)	2019-12-17	2022-11-25	辉瑞大药厂	对cd47、pd-l1具特异性的抗体及其用途
AU2021308586A1 (en)	2020-07-17	2023-03-02	Pfizer Inc.	Therapeutic antibodies and their uses
CA3190606A1 (en)	2020-08-20	2022-02-24	Ambrx, Inc.	Antibody-tlr agonist conjugates, methods and uses thereof

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2135210A (en) *	1937-03-13	1938-11-01	John R Farrar	Golf ball
US3314941A (en)	1964-06-23	1967-04-18	American Cyanamid Co	Novel substituted pyridodiazepins
US3692907A (en) *	1970-10-27	1972-09-19	Richardson Merrell Inc	Treating viral infections with bis-basic ethers and thioethers of fluorenone and fluorene and pharmaceutical compositons of the same
US3819190A (en) *	1972-10-02	1974-06-25	D Nepela	Golf ball
US4284276A (en) *	1980-02-13	1981-08-18	Worst Joseph C	Grooved golf ball
ZA848968B (en)	1983-11-18	1986-06-25	Riker Laboratories Inc	1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
IL73534A (en)	1983-11-18	1990-12-23	Riker Laboratories Inc	1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US4880779A (en) *	1987-07-31	1989-11-14	Research Corporation Technologies, Inc.	Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
US5238944A (en)	1988-12-15	1993-08-24	Riker Laboratories, Inc.	Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
US5756747A (en)	1989-02-27	1998-05-26	Riker Laboratories, Inc.	1H-imidazo 4,5-c!quinolin-4-amines
US4929624A (en)	1989-03-23	1990-05-29	Minnesota Mining And Manufacturing Company	Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5037986A (en)	1989-03-23	1991-08-06	Minnesota Mining And Manufacturing Company	Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
NZ232740A (en)	1989-04-20	1992-06-25	Riker Laboratories Inc	Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
US4988815A (en) *	1989-10-26	1991-01-29	Riker Laboratories, Inc.	3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
US5054153A (en) *	1989-12-01	1991-10-08	Silliman Paul D	Golf club cleaner
ES2071340T3 (es) *	1990-10-05	1995-06-16	Minnesota Mining & Mfg	Procedimiento para la preparacion de imidazo(4,5-c)quinolin-4-aminas.
US5175296A (en) *	1991-03-01	1992-12-29	Minnesota Mining And Manufacturing Company	Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
US5389640A (en)	1991-03-01	1995-02-14	Minnesota Mining And Manufacturing Company	1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
ES2131070T3 (es) *	1991-03-01	1999-07-16	Minnesota Mining & Mfg	1h-imidazo(4,5-c)quinolin-4-aminas sustituidas en posicion 1 y sustituidas en posicion 2.
US5268376A (en)	1991-09-04	1993-12-07	Minnesota Mining And Manufacturing Company	1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5266575A (en)	1991-11-06	1993-11-30	Minnesota Mining And Manufacturing Company	2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en)	1992-04-16	1996-11-14	Minnesota Mining & Mfg	Immunogen/vaccine adjuvant composition
FR2692159B1 (fr) *	1992-06-10	1996-10-11	Vartan Berberian	Boule pour jeux de boules et procedes d'obtention d'une telle boule.
US5395937A (en) *	1993-01-29	1995-03-07	Minnesota Mining And Manufacturing Company	Process for preparing quinoline amines
US5648516A (en)	1994-07-20	1997-07-15	Minnesota Mining And Manufacturing Company	Fused cycloalkylimidazopyridines
EP0708772B1 (en)	1993-07-15	2000-08-23	Minnesota Mining And Manufacturing Company	IMIDAZO [4,5-c]PYRIDIN-4-AMINES
US5352784A (en) *	1993-07-15	1994-10-04	Minnesota Mining And Manufacturing Company	Fused cycloalkylimidazopyridines
US5644063A (en)	1994-09-08	1997-07-01	Minnesota Mining And Manufacturing Company	Imidazo[4,5-c]pyridin-4-amine intermediates
US5482936A (en)	1995-01-12	1996-01-09	Minnesota Mining And Manufacturing Company	Imidazo[4,5-C]quinoline amines
JPH09116911A (ja) *	1995-10-20	1997-05-02	Canon Inc	撮像システム
JPH09208584A (ja)	1996-01-29	1997-08-12	Terumo Corp	アミド誘導体、およびそれを含有する医薬製剤、および合成中間体
JPH09255926A (ja)	1996-03-26	1997-09-30	Diatex Co Ltd	粘着テープ
US5741908A (en) *	1996-06-21	1998-04-21	Minnesota Mining And Manufacturing Company	Process for reparing imidazoquinolinamines
US5693811A (en) *	1996-06-21	1997-12-02	Minnesota Mining And Manufacturing Company	Process for preparing tetrahdroimidazoquinolinamines
US5759109A (en) *	1996-09-09	1998-06-02	Martini; Byron Rocco	Simulated golf ball instructional device
WO1998017279A1 (en) *	1996-10-25	1998-04-30	Minnesota Mining And Manufacturing Company	Immune response modifier compounds for treatment of th2 mediated and related diseases
US5939090A (en)	1996-12-03	1999-08-17	3M Innovative Properties Company	Gel formulations for topical drug delivery
EP0894797A4 (en)	1997-01-09	2001-08-16	Terumo Corp	NEW AMID DERIVATIVES AND INTERMEDIATES ON YOUR SYNTHESIS
UA67760C2 (uk) *	1997-12-11	2004-07-15	Міннесота Майнінг Енд Мануфакчурінг Компані	Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
JPH11222432A (ja)	1998-02-03	1999-08-17	Terumo Corp	インターフェロンを誘起するアミド誘導体を含有する外用剤
JPH11255926A (ja)	1998-03-13	1999-09-21	Toray Ind Inc	シリコーン成型品およびその製造方法
US6239965B1 (en) *	1998-05-22	2001-05-29	Matsushita Electric Industrial Co., Ltd.	Electrolytic capacitor and method of producing the same
US6110929A (en)	1998-07-28	2000-08-29	3M Innovative Properties Company	Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
JP2000119271A (ja) *	1998-08-12	2000-04-25	Hokuriku Seiyaku Co Ltd	１ｈ―イミダゾピリジン誘導体
US20020058674A1 (en) *	1999-01-08	2002-05-16	Hedenstrom John C.	Systems and methods for treating a mucosal surface
PL349773A1 (en) *	1999-01-08	2002-09-09	3M Innovative Properties Co	Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions
US6558951B1 (en) *	1999-02-11	2003-05-06	3M Innovative Properties Company	Maturation of dendritic cells with immune response modifying compounds
JP2000247884A (ja)	1999-03-01	2000-09-12	Sumitomo Pharmaceut Co Ltd	アラキドン酸誘発皮膚疾患治療剤
US6331539B1 (en)	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6756382B2 (en)	1999-06-10	2004-06-29	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6451810B1 (en) *	1999-06-10	2002-09-17	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6541485B1 (en)	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6573273B1 (en) *	1999-06-10	2003-06-03	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6376669B1 (en) *	1999-11-05	2002-04-23	3M Innovative Properties Company	Dye labeled imidazoquinoline compounds
US6894060B2 (en)	2000-03-30	2005-05-17	3M Innovative Properties Company	Method for the treatment of dermal lesions caused by envenomation
US20020055517A1 (en) *	2000-09-15	2002-05-09	3M Innovative Properties Company	Methods for delaying recurrence of herpes virus symptoms
JP2002145777A (ja)	2000-11-06	2002-05-22	Sumitomo Pharmaceut Co Ltd	アラキドン酸誘発皮膚疾患治療剤
US6545017B1 (en) *	2000-12-08	2003-04-08	3M Innovative Properties Company	Urea substituted imidazopyridines
US6664265B2 (en) *	2000-12-08	2003-12-16	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6677347B2 (en) *	2000-12-08	2004-01-13	3M Innovative Properties Company	Sulfonamido ether substituted imidazoquinolines
CA2430206A1 (en)	2000-12-08	2002-06-13	3M Innovative Properties Company	Screening method for identifying compounds that selectively induce interferon alpha
US6660735B2 (en) *	2000-12-08	2003-12-09	3M Innovative Properties Company	Urea substituted imidazoquinoline ethers
US6660747B2 (en)	2000-12-08	2003-12-09	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6525064B1 (en)	2000-12-08	2003-02-25	3M Innovative Properties Company	Sulfonamido substituted imidazopyridines
US6664264B2 (en) *	2000-12-08	2003-12-16	3M Innovative Properties Company	Thioether substituted imidazoquinolines
UA74593C2 (en)	2000-12-08	2006-01-16	3M Innovative Properties Co	Substituted imidazopyridines
US6545016B1 (en) *	2000-12-08	2003-04-08	3M Innovative Properties Company	Amide substituted imidazopyridines
UA74852C2 (en)	2000-12-08	2006-02-15	3M Innovative Properties Co	Urea-substituted imidazoquinoline ethers
US6667312B2 (en)	2000-12-08	2003-12-23	3M Innovative Properties Company	Thioether substituted imidazoquinolines
US6664260B2 (en)	2000-12-08	2003-12-16	3M Innovative Properties Company	Heterocyclic ether substituted imidazoquinolines
US6677348B2 (en)	2000-12-08	2004-01-13	3M Innovative Properties Company	Aryl ether substituted imidazoquinolines
WO2002102377A1 (en)	2001-06-15	2002-12-27	3M Innovative Properties Company	Immune response modifiers for the treatment of periodontal disease
WO2003020889A2 (en)	2001-08-30	2003-03-13	3M Innovative Properties Company	Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
JP2005519990A (ja)	2001-10-12	2005-07-07	ユニバーシティオブアイオワリサーチファウンデーション	イミダゾキノリン化合物を用いて免疫応答を増強するための方法および産物
ATE416771T1 (de)	2001-11-16	2008-12-15	3M Innovative Properties Co	N-ä4-(4-amino-2-ethyl-1h-imidazoä4,5-cüchinolin 1-yl)butylümethanesulfonamide, diese enthaltende pharmazeutische zusammensetzung und deren verwendung
ES2312659T3 (es)	2001-11-29	2009-03-01	3M Innovative Properties Company	Formulaciones farmaceuticas que comprenden un modificador de la respuesta inmune.
US6677349B1 (en)	2001-12-21	2004-01-13	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
NZ534566A (en)	2002-02-22	2007-02-23	3M Innovative Properties Co	Method of reducing and treating UVB-induced immunosuppression
GB0211649D0 (en)	2002-05-21	2002-07-03	Novartis Ag	Organic compounds
WO2003101949A2 (en)	2002-05-29	2003-12-11	3M Innovative Properties Company	Process for imidazo[4,5-c]pyridin-4-amines
CN1674894A (zh)	2002-06-07	2005-09-28	3M创新有限公司	醚取代的咪唑并吡啶
BR0313587A (pt)	2002-08-15	2006-06-13	3M Innovative Properties Co	composições imunoestimuladoras e métodos de estimulação de uma resposta imune
WO2004028539A2 (en)	2002-09-26	2004-04-08	3M Innovative Properties Company	1h-imidazo dimers
AU2003287324A1 (en)	2002-12-11	2004-06-30	3M Innovative Properties Company	Gene expression systems and recombinant cell lines
WO2004053452A2 (en)	2002-12-11	2004-06-24	3M Innovative Properties Company	Assays relating to toll-like receptor activity
NZ540826A (en) *	2002-12-20	2008-07-31	3M Innovative Properties Co	Aryl / hetaryl substituted imidazoquinolines
JP2006512391A (ja)	2002-12-30	2006-04-13	スリーエムイノベイティブプロパティズカンパニー	組み合わせ免疫賦活薬
US7375180B2 (en)	2003-02-13	2008-05-20	3M Innovative Properties Company	Methods and compositions related to IRM compounds and Toll-like receptor 8
EP1599726A4 (en)	2003-02-27	2009-07-22	3M Innovative Properties Co	SELECTIVE MODULATION OF TLR-MEDIATED BIOLOGICAL ACTIVITY
WO2004078138A2 (en)	2003-03-04	2004-09-16	3M Innovative Properties Company	Prophylactic treatment of uv-induced epidermal neoplasia
WO2004080398A2 (en)	2003-03-07	2004-09-23	3M Innovative Properties Company	1-amino 1h-imidazoquinolines
EP1608282A4 (en)	2003-03-13	2010-12-08	3M Innovative Properties Co	METHODS OF DIAGNOSING SKIN LESIONS
AU2004220465A1 (en)	2003-03-13	2004-09-23	3M Innovative Properties Company	Method of tattoo removal
NZ567227A (en)	2003-03-13	2010-01-29	3M Innovative Properties Co	Methods of improving skin quality through topical application of an immune response modifier such as imiquimod
EP1613956A2 (en)	2003-03-25	2006-01-11	3M Innovative Properties Company	Selective activation of cellular activities mediated through a common toll-like receptor
US20040192585A1 (en)	2003-03-25	2004-09-30	3M Innovative Properties Company	Treatment for basal cell carcinoma
AU2004244962A1 (en)	2003-04-10	2004-12-16	3M Innovative Properties Company	Delivery of immune response modifier compounds using metal-containing particulate support materials
EA200600540A1 (ru)	2003-09-05	2006-08-25	Анадис Фармасьютикалз, Инк.	Введение лигандов tlr7 и их пролекарств для лечения инфекции вируса гепатита с

2001
- 2001-06-12 UA UA2003065275A patent/UA74852C2/uk unknown
- 2001-06-12 UA UA2003065277A patent/UA75622C2/uk unknown
- 2001-12-06 AU AU3951602A patent/AU3951602A/xx active Pending
- 2001-12-06 IL IL15595001A patent/IL155950A0/xx unknown
- 2001-12-06 EE EEP200300270A patent/EE200300270A/xx unknown
- 2001-12-06 MX MXPA03004975A patent/MXPA03004975A/es active IP Right Grant
- 2001-12-06 BR BR0116026-5A patent/BR0116026A/pt not_active IP Right Cessation
- 2001-12-06 DE DE60117859T patent/DE60117859T2/de not_active Expired - Fee Related
- 2001-12-06 WO PCT/US2001/046581 patent/WO2002046189A2/en active IP Right Grant
- 2001-12-06 EE EEP200300275A patent/EE200300275A/xx unknown
- 2001-12-06 IL IL15590301A patent/IL155903A0/xx unknown
- 2001-12-06 MX MXPA03005012A patent/MXPA03005012A/es active IP Right Grant
- 2001-12-06 MX MXPA03004972A patent/MXPA03004972A/es active IP Right Grant
- 2001-12-06 KR KR10-2003-7007534A patent/KR20030070049A/ko active IP Right Grant
- 2001-12-06 CN CNA018201687A patent/CN1479739A/zh active Pending
- 2001-12-06 DE DE60126645T patent/DE60126645T2/de not_active Expired - Fee Related
- 2001-12-06 PL PL01361948A patent/PL361948A1/xx not_active Application Discontinuation
- 2001-12-06 AU AU3951702A patent/AU3951702A/xx active Pending
- 2001-12-06 MX MXPA03005011A patent/MXPA03005011A/es active IP Right Grant
- 2001-12-06 DK DK01992018T patent/DK1343784T3/da active
- 2001-12-06 BR BRPI0116032-0A patent/BR0116032A/pt not_active IP Right Cessation
- 2001-12-06 AU AU3248202A patent/AU3248202A/xx active Pending
- 2001-12-06 PL PL392462A patent/PL392462A1/pl unknown
- 2001-12-06 RU RU2003116063/04A patent/RU2003116063A/ru not_active Application Discontinuation
- 2001-12-06 WO PCT/US2001/046704 patent/WO2002046193A2/en active IP Right Grant
- 2001-12-06 HU HU0600600A patent/HUP0600600A2/hu unknown
- 2001-12-06 NZ NZ526089A patent/NZ526089A/en unknown
- 2001-12-06 CA CA002436983A patent/CA2436983A1/en not_active Abandoned
- 2001-12-06 BR BR0116047-8A patent/BR0116047A/pt not_active IP Right Cessation
- 2001-12-06 KR KR10-2003-7007539A patent/KR20040047733A/ko not_active Application Discontinuation
- 2001-12-06 AU AU3061802A patent/AU3061802A/xx active Pending
- 2001-12-06 EE EEP200300274A patent/EE200300274A/xx unknown
- 2001-12-06 SK SK712-2003A patent/SK7122003A3/sk unknown
- 2001-12-06 IL IL15604301A patent/IL156043A0/xx unknown
- 2001-12-06 JP JP2002547928A patent/JP2004521092A/ja not_active Ceased
- 2001-12-06 AU AU3249702A patent/AU3249702A/xx active Pending
- 2001-12-06 NZ NZ526106A patent/NZ526106A/en not_active IP Right Cessation
- 2001-12-06 EP EP01987297A patent/EP1341791B1/en not_active Expired - Lifetime
- 2001-12-06 SK SK711-2003A patent/SK7112003A3/sk unknown
- 2001-12-06 AU AU2002239517A patent/AU2002239517B2/en not_active Ceased
- 2001-12-06 WO PCT/US2001/046582 patent/WO2002046190A2/en active IP Right Grant
- 2001-12-06 HU HU0700062A patent/HUP0700062A2/hu active IP Right Revival
- 2001-12-06 CN CNB01820161XA patent/CN1253452C/zh not_active Expired - Fee Related
- 2001-12-06 HU HU0400710A patent/HUP0400710A2/hu unknown
- 2001-12-06 CA CA2436980A patent/CA2436980C/en not_active Expired - Fee Related
- 2001-12-06 SK SK715-2003A patent/SK7152003A3/sk unknown
- 2001-12-06 NZ NZ526088A patent/NZ526088A/xx unknown
- 2001-12-06 SK SK713-2003A patent/SK287732B6/sk not_active IP Right Cessation
- 2001-12-06 PL PL366330A patent/PL207340B1/pl not_active IP Right Cessation
- 2001-12-06 CZ CZ20031561A patent/CZ20031561A3/cs unknown
- 2001-12-06 WO PCT/US2001/046359 patent/WO2002046188A2/en active IP Right Grant
- 2001-12-06 NZ NZ526087A patent/NZ526087A/en unknown
- 2001-12-06 WO PCT/US2001/046696 patent/WO2002046191A2/en active IP Right Grant
- 2001-12-06 ES ES01987297T patent/ES2242782T3/es not_active Expired - Lifetime
- 2001-12-06 AU AU2002239530A patent/AU2002239530B2/en not_active Ceased
- 2001-12-06 NZ NZ526105A patent/NZ526105A/en unknown
- 2001-12-06 PL PL01365907A patent/PL365907A1/xx not_active Application Discontinuation
- 2001-12-06 EE EEP200300272A patent/EE200300272A/xx unknown
- 2001-12-06 IL IL15588401A patent/IL155884A0/xx unknown
- 2001-12-06 CZ CZ20031592A patent/CZ303462B6/cs not_active IP Right Cessation
- 2001-12-06 IL IL15590401A patent/IL155904A0/xx unknown
- 2001-12-06 EP EP01992005A patent/EP1341792A2/en not_active Withdrawn
- 2001-12-06 MX MXPA03004974A patent/MXPA03004974A/es active IP Right Grant
- 2001-12-06 HU HU0400704A patent/HUP0400704A2/hu unknown
- 2001-12-06 KR KR10-2003-7007532A patent/KR20040023576A/ko not_active Application Discontinuation
- 2001-12-06 JP JP2002547926A patent/JP2004523498A/ja active Pending
- 2001-12-06 AT AT01987297T patent/ATE296301T1/de active
- 2001-12-06 KR KR10-2003-7007537A patent/KR20030070050A/ko not_active Application Discontinuation
- 2001-12-06 CN CNB018201598A patent/CN1247575C/zh not_active Expired - Fee Related
- 2001-12-06 AU AU3953002A patent/AU3953002A/xx active Pending
- 2001-12-06 AT AT01992018T patent/ATE319711T1/de not_active IP Right Cessation
- 2001-12-06 HU HU0600605A patent/HUP0600605A2/hu unknown
- 2001-12-06 DK DK01987297T patent/DK1341791T3/da active
- 2001-12-06 BR BR0116470-8A patent/BR0116470A/pt not_active IP Right Cessation
- 2001-12-06 RU RU2003116059/04A patent/RU2308456C2/ru not_active IP Right Cessation
- 2001-12-06 CN CNB018201679A patent/CN1297554C/zh not_active Expired - Fee Related
- 2001-12-06 IL IL15604401A patent/IL156044A0/xx unknown
- 2001-12-06 CN CNA018201725A patent/CN1894244A/zh active Pending
- 2001-12-06 EP EP01992018A patent/EP1343784B1/en not_active Expired - Lifetime
- 2001-12-06 MX MXPA03004973A patent/MXPA03004973A/es not_active Application Discontinuation
- 2001-12-06 US US10/013,060 patent/US6656938B2/en not_active Expired - Fee Related
- 2001-12-06 US US10/012,599 patent/US6683088B2/en not_active Expired - Fee Related
- 2001-12-06 SK SK684-2003A patent/SK6842003A3/sk not_active Application Discontinuation
- 2001-12-06 JP JP2002547925A patent/JP4437189B2/ja not_active Expired - Fee Related
- 2001-12-06 JP JP2002547927A patent/JP2004529078A/ja active Pending
- 2001-12-06 CA CA002431151A patent/CA2431151A1/en not_active Withdrawn
- 2001-12-06 CZ CZ20031563A patent/CZ20031563A3/cs unknown
- 2001-12-06 JP JP2002547930A patent/JP2004515501A/ja active Pending
- 2001-12-06 CZ CZ20031591A patent/CZ20031591A3/cs unknown
- 2001-12-06 KR KR10-2003-7007538A patent/KR20040028691A/ko not_active Application Discontinuation
- 2001-12-06 CZ CZ20031560A patent/CZ295848B6/cs not_active IP Right Cessation
- 2001-12-06 RU RU2003116061/04A patent/RU2315049C2/ru not_active IP Right Cessation
- 2001-12-06 PT PT01987297T patent/PT1341791E/pt unknown
- 2001-12-06 PL PL01365995A patent/PL365995A1/xx unknown
- 2001-12-06 ES ES01987283T patent/ES2281456T3/es not_active Expired - Lifetime
- 2001-12-06 RU RU2003116060/04A patent/RU2302418C2/ru active
- 2001-12-06 PL PL01366115A patent/PL366115A1/xx not_active Application Discontinuation
- 2001-12-06 NZ NZ526086A patent/NZ526086A/en unknown
- 2001-12-06 CA CA002436984A patent/CA2436984A1/en not_active Abandoned
- 2001-12-06 BR BRPI0116052-4A patent/BR0116052A/pt not_active Application Discontinuation
- 2001-12-06 WO PCT/US2001/046697 patent/WO2002046192A2/en active IP Right Grant
- 2001-12-06 AU AU2002239516A patent/AU2002239516B2/en not_active Ceased
- 2001-12-06 KR KR10-2003-7007535A patent/KR20040028690A/ko not_active Application Discontinuation
- 2001-12-06 US US10/013,202 patent/US6670372B2/en not_active Expired - Fee Related
- 2001-12-06 RU RU2003116123/04A patent/RU2003116123A/ru not_active Application Discontinuation
- 2001-12-06 EE EEP200300271A patent/EE200300271A/xx unknown
- 2001-12-06 SI SI200130720T patent/SI1341790T1/sl unknown
- 2001-12-06 SK SK710-2003A patent/SK287264B6/sk not_active IP Right Cessation
- 2001-12-06 CN CNB018199070A patent/CN1252070C/zh not_active Expired - Fee Related
- 2001-12-06 PT PT01987283T patent/PT1341790E/pt unknown
- 2001-12-06 CZ CZ20031562A patent/CZ20031562A3/cs unknown
- 2001-12-06 RU RU2003116649/04A patent/RU2351598C2/ru not_active IP Right Cessation
- 2001-12-06 ES ES01992018T patent/ES2260323T3/es not_active Expired - Lifetime
- 2001-12-06 EE EEP200300268A patent/EE200300268A/xx unknown
- 2001-12-06 BR BRPI0116464-3A patent/BR0116464A/pt not_active IP Right Cessation
- 2001-12-06 AU AU2002230618A patent/AU2002230618B2/en not_active Ceased
- 2001-12-06 EP EP01987283A patent/EP1341790B1/en not_active Expired - Lifetime
- 2001-12-06 DE DE60111076T patent/DE60111076T2/de not_active Expired - Lifetime
- 2001-12-06 CA CA002430844A patent/CA2430844A1/en not_active Withdrawn
- 2001-12-06 EP EP01990852A patent/EP1339715A2/en not_active Withdrawn
- 2001-12-06 AU AU2002232497A patent/AU2002232497B2/en not_active Ceased
- 2001-12-06 AU AU2002232482A patent/AU2002232482B2/en not_active Ceased
- 2001-12-06 CA CA2436846A patent/CA2436846C/en not_active Expired - Fee Related
- 2001-12-06 AT AT01987283T patent/ATE353895T1/de not_active IP Right Cessation
- 2001-12-06 HU HU0600338A patent/HUP0600338A2/hu active IP Right Revival
- 2001-12-06 JP JP2002547929A patent/JP2004515500A/ja not_active Withdrawn
- 2001-12-06 EP EP01987282A patent/EP1341789A2/en not_active Ceased
- 2001-12-06 PL PL01365883A patent/PL365883A1/xx not_active Application Discontinuation
- 2001-12-06 DK DK01987283T patent/DK1341790T3/da active
- 2001-12-07 TW TW090130402A patent/TWI222972B/zh active
- 2001-12-07 TW TW090130401A patent/TW584633B/zh not_active IP Right Cessation
- 2001-12-07 TW TW090130404A patent/TWI293300B/zh active
- 2001-12-10 AR ARP010105731A patent/AR035669A1/es unknown
- 2001-12-10 AR ARP010105728A patent/AR035666A1/es unknown
- 2001-12-10 AR ARP010105730A patent/AR035668A1/es unknown
- 2001-12-10 AR ARP010105726A patent/AR035664A1/es active IP Right Grant
- 2001-12-10 AR ARP010105729A patent/AR035667A1/es unknown
- 2001-12-10 AR ARP010105727A patent/AR035665A1/es unknown
2003
- 2003-05-28 NO NO20032451A patent/NO20032451L/no not_active Application Discontinuation
- 2003-05-28 NO NO20032452A patent/NO20032452L/no not_active Application Discontinuation
- 2003-05-28 NO NO20032449A patent/NO20032449D0/no not_active Application Discontinuation
- 2003-05-30 NO NO20032473A patent/NO326159B1/no not_active IP Right Cessation
- 2003-06-06 HR HR20030463A patent/HRP20030463A2/xx not_active Application Discontinuation
- 2003-06-06 HR HR20030461A patent/HRP20030461A2/hr not_active Application Discontinuation
- 2003-06-06 HR HR20030462A patent/HRP20030462A2/xx not_active Application Discontinuation
- 2003-06-06 HR HR20030467A patent/HRP20030467B1/xx not_active IP Right Cessation
- 2003-06-06 HR HR20030466A patent/HRP20030466A2/hr not_active Application Discontinuation
- 2003-06-06 NO NO20032595A patent/NO20032595L/no not_active Application Discontinuation
- 2003-06-06 HR HR20030464A patent/HRP20030464A2/hr not_active Application Discontinuation
- 2003-06-06 NO NO20032596A patent/NO20032596L/no not_active Application Discontinuation
- 2003-07-08 ZA ZA200305274A patent/ZA200305274B/en unknown
- 2003-07-08 ZA ZA200305273A patent/ZA200305273B/en unknown
- 2003-07-08 ZA ZA2003/05272A patent/ZA200305272B/en unknown
- 2003-07-08 ZA ZA200305271A patent/ZA200305271B/en unknown
- 2003-07-08 ZA ZA200305270A patent/ZA200305270B/en unknown
- 2003-07-08 ZA ZA200305275A patent/ZA200305275B/en unknown
- 2003-10-07 US US10/680,989 patent/US7049439B2/en not_active Expired - Fee Related
- 2003-10-29 US US10/696,753 patent/US6953804B2/en not_active Expired - Fee Related
- 2003-10-29 US US10/696,476 patent/US20040092545A1/en not_active Abandoned
2004
- 2004-09-20 HK HK04107230A patent/HK1064383A1/xx not_active IP Right Cessation
- 2004-11-11 HK HK04108904A patent/HK1066005A1/xx not_active IP Right Cessation
2005
- 2005-01-25 HK HK05100647A patent/HK1069166A1/xx not_active IP Right Cessation
- 2005-02-28 US US11/069,033 patent/US7132429B2/en not_active Expired - Fee Related
- 2005-05-19 US US11/132,900 patent/US7612083B2/en not_active Expired - Fee Related
- 2005-08-24 CY CY20051101024T patent/CY1105586T1/el unknown
2007
- 2007-05-09 CY CY20071100621T patent/CY1106569T1/el unknown
2009
- 2009-11-06 JP JP2009255040A patent/JP2010031040A/ja not_active Ceased

Also Published As

Publication number	Publication date
RU2308456C2 (ru)	2007-10-20
NZ526088A (en)	2004-12-24
PL365907A1 (en)	2005-01-10
US20050148619A1 (en)	2005-07-07
CN1511155A (zh)	2004-07-07
CA2430844A1 (en)	2002-06-13
WO2002046192A3 (en)	2003-02-13
BR0116470A (pt)	2005-08-16
NO20032473D0 (no)	2003-05-30
CN1487939A (zh)	2004-04-07
MXPA03005011A (es)	2003-09-05
SI1341790T1 (sl)	2007-06-30
HK1066005A1 (en)	2005-03-11
HRP20030467A2 (en)	2004-04-30
AU2002230618B2 (en)	2006-11-02
MXPA03004975A (es)	2003-09-05
EE200300271A (et)	2003-10-15
DK1341791T3 (da)	2005-09-19
JP2004521092A (ja)	2004-07-15
JP2004523498A (ja)	2004-08-05
US20040077678A1 (en)	2004-04-22
CZ20031592A3 (cs)	2004-01-14
DE60111076T2 (de)	2006-05-04
US20030212091A1 (en)	2003-11-13
CN1252070C (zh)	2006-04-19
TWI293300B (en)	2008-02-11
JP2010031040A (ja)	2010-02-12
CA2436980A1 (en)	2002-06-13
NO20032452D0 (no)	2003-05-28
ES2260323T3 (es)	2006-11-01
BR0116052A (pt)	2006-02-21
AU2002232497B2 (en)	2006-11-02
NZ526106A (en)	2004-11-26
NO326159B1 (no)	2008-10-13
IL155904A0 (en)	2003-12-23
ES2242782T3 (es)	2005-11-16
HRP20030464A2 (en)	2004-06-30
PL366330A1 (en)	2005-01-24
WO2002046189A2 (en)	2002-06-13
SK287264B6 (sk)	2010-04-07
NO20032449L (no)	2003-05-28
AR035667A1 (es)	2004-06-23
ES2281456T3 (es)	2007-10-01
HUP0400710A2 (hu)	2004-06-28
KR20040023576A (ko)	2004-03-18
UA74852C2 (en)	2006-02-15
DE60126645T2 (de)	2007-11-22
CZ303462B6 (cs)	2012-09-26
CZ20031560A3 (en)	2004-05-12
EE200300272A (et)	2003-10-15
PL361948A1 (en)	2004-10-18
SK7152003A3 (en)	2003-09-11
TW584633B (en)	2004-04-21
CA2431151A1 (en)	2002-06-13
SK7132003A3 (en)	2003-10-07
CZ20031563A3 (cs)	2004-02-18
EP1341789A2 (en)	2003-09-10
WO2002046188A3 (en)	2003-03-13
MXPA03005012A (es)	2003-09-05
HK1064383A1 (en)	2005-01-28
CN1537111A (zh)	2004-10-13
WO2002046193A3 (en)	2003-02-27
SK287732B6 (en)	2011-07-06
HRP20030462A2 (en)	2004-04-30
JP2004529078A (ja)	2004-09-24
US6953804B2 (en)	2005-10-11
PL392462A1 (pl)	2010-11-22
AU3951602A (en)	2002-06-18
CA2436983A1 (en)	2002-06-13
HUP0600600A2 (en)	2006-11-28
HK1069166A1 (en)	2005-05-13
EP1343784A2 (en)	2003-09-17
AU3951702A (en)	2002-06-18
EE200300274A (et)	2003-10-15
AU3249702A (en)	2002-06-18
TWI222972B (en)	2004-11-01
HRP20030466A2 (en)	2004-06-30
BR0116032A (pt)	2006-02-21
SK7122003A3 (en)	2003-11-04
CA2436846C (en)	2010-11-16
HUP0600605A2 (en)	2006-11-28
WO2002046193A2 (en)	2002-06-13
EE200300275A (et)	2003-10-15
CZ20031562A3 (en)	2004-03-17
CN1894244A (zh)	2007-01-10
WO2002046189A3 (en)	2003-03-20
NO20032449D0 (no)	2003-05-28
EP1339715A2 (en)	2003-09-03
CN1297554C (zh)	2007-01-31
RU2302418C2 (ru)	2007-07-10
PT1341791E (pt)	2005-09-30
US20040092545A1 (en)	2004-05-13
EP1341791B1 (en)	2005-05-25
MXPA03004973A (es)	2004-01-29
WO2002046191A3 (en)	2003-03-13
UA75622C2 (en)	2006-05-15
AR035664A1 (es)	2004-06-23
AU3061802A (en)	2002-06-18
ZA200305274B (en)	2004-10-18
CN1253452C (zh)	2006-04-26
SK7102003A3 (en)	2003-10-07
US7612083B2 (en)	2009-11-03
CN1479738A (zh)	2004-03-03
AR035665A1 (es)	2004-06-23
DE60111076D1 (en)	2005-06-30
DK1341790T3 (da)	2007-06-04
NZ526087A (en)	2004-11-26
ZA200305272B (en)	2005-01-26
CA2436980C (en)	2011-03-29
CN1247575C (zh)	2006-03-29
EP1341792A2 (en)	2003-09-10
US7132429B2 (en)	2006-11-07
EP1343784B1 (en)	2006-03-08
EE200300270A (et)	2003-10-15
NO20032596D0 (no)	2003-06-06
US20040106640A1 (en)	2004-06-03
RU2003116063A (ru)	2004-12-10
HUP0400704A2 (hu)	2004-06-28
NZ526089A (en)	2004-11-26
AR035669A1 (es)	2004-06-23
BR0116464A (pt)	2006-02-21
NO20032595D0 (no)	2003-06-06
CA2436984A1 (en)	2002-06-13
AU3248202A (en)	2002-06-18
HUP0600338A2 (en)	2006-08-28
AR035666A1 (es)	2004-06-23
WO2002046190A3 (en)	2003-07-17
PT1341790E (pt)	2007-05-31
ZA200305271B (en)	2004-10-08
NO20032595L (no)	2003-06-06
CY1106569T1 (el)	2012-01-25
AR035668A1 (es)	2004-06-23
HUP0700062A2 (en)	2007-05-02
MXPA03004972A (es)	2004-01-29
AU2002239516B2 (en)	2006-11-09
US7049439B2 (en)	2006-05-23
JP2004532810A (ja)	2004-10-28
IL156044A0 (en)	2003-12-23
NO20032451D0 (no)	2003-05-28
WO2002046188A2 (en)	2002-06-13
NO20032596L (no)	2003-06-06
DK1343784T3 (da)	2006-07-10
RU2003116059A (ru)	2005-02-10
ZA200305273B (en)	2004-10-08
DE60117859D1 (de)	2006-05-04
US20020193396A1 (en)	2002-12-19
MXPA03004974A (es)	2003-09-05
ZA200305275B (en)	2004-10-08
WO2002046191A2 (en)	2002-06-13
ATE296301T1 (de)	2005-06-15
CZ295848B6 (cs)	2005-11-16
WO2002046192A2 (en)	2002-06-13
ZA200305270B (en)	2004-08-26
KR20040028691A (ko)	2004-04-03
PL365995A1 (en)	2005-01-24
BR0116026A (pt)	2004-12-21
EP1341790B1 (en)	2007-02-14
KR20030070050A (ko)	2003-08-27
HRP20030461A2 (en)	2004-06-30
IL155884A0 (en)	2003-12-23
KR20040047733A (ko)	2004-06-05
NO20032451L (no)	2003-07-16
KR20040028690A (ko)	2004-04-03
RU2351598C2 (ru)	2009-04-10
JP2004515501A (ja)	2004-05-27
NZ526105A (en)	2004-11-26
EP1341790A2 (en)	2003-09-10
CA2436846A1 (en)	2002-06-13
PL365883A1 (en)	2005-01-10
SK6842003A3 (en)	2003-12-02
NO20032452L (no)	2003-07-16
DE60117859T2 (de)	2006-11-23
RU2003116649A (ru)	2005-02-10
EE200300268A (et)	2003-10-15
CZ20031591A3 (cs)	2003-11-12
KR20030070049A (ko)	2003-08-27
CN1479739A (zh)	2004-03-03
US6670372B2 (en)	2003-12-30
HRP20030467B1 (en)	2009-04-30
US20030158192A1 (en)	2003-08-21
NO20032473L (no)	2003-05-30
SK7112003A3 (en)	2003-12-02
DE60126645D1 (de)	2007-03-29
ATE319711T1 (de)	2006-03-15
RU2315049C2 (ru)	2008-01-20
PL366115A1 (en)	2005-01-24
IL156043A0 (en)	2003-12-23
AU2002232482B2 (en)	2006-10-19
AU2002239517B2 (en)	2006-11-02
PL207340B1 (pl)	2010-12-31
AU3953002A (en)	2002-06-18
AU2002239530B2 (en)	2006-09-28
RU2003116123A (ru)	2004-11-20
ATE353895T1 (de)	2007-03-15
EP1341791A2 (en)	2003-09-10
US6656938B2 (en)	2003-12-02
BR0116047A (pt)	2003-09-30
CZ20031561A3 (cs)	2004-04-14
HRP20030463A2 (en)	2004-04-30
US20050234088A1 (en)	2005-10-20
CY1105586T1 (el)	2010-07-28
US6683088B2 (en)	2004-01-27
WO2002046190A2 (en)	2002-06-13
IL155903A0 (en)	2003-12-23
JP4437189B2 (ja)	2010-03-24
JP2004515500A (ja)	2004-05-27
NZ526086A (en)	2005-11-25

Publication	Publication Date	Title
AU3061802A (en)	2002-06-18	Heterocyclic ether substituted imidazoquinolines
AU6053701A (en)	2001-12-17	2-aminocarbonyl-9h-purine derivatives
IL155103A0 (en)	2003-10-31	Substituted c-cyclohexylmethylamine derivatives
IL152979A0 (en)	2003-06-24	Heterocyclic compounds
AU8993701A (en)	2002-04-15	Substituted 1-aminobutan-3-ol derivatives
IL150557A0 (en)	2003-02-12	Substituted aminomethyl-phenyl-cyclohexane derivatives
IL150506A0 (en)	2003-02-12	New imidazole derivatives
IL155104A0 (en)	2003-10-31	5-amino-1-pentene-3-ol substituted derivatives
HK1048117A1 (zh)	2003-03-21	2-苯基吡喃-4-酮衍生物
GB0009452D0 (en)	2000-06-07	PTP1B-Inhibiting heterocyclic derivatives
GB0001993D0 (en)	2000-03-22	Heterocyclic derivatives
GB0001972D0 (en)	2000-03-22	Heterocyclic derivatives
SI1322590T1 (sl)	2007-10-31	Substituirani 5-amino-1-penten-3-olni derivati
SI1246793T1 (en)	2005-06-30	Substituted aminomethyl-phenyl-cyclohexane derivatives
GB0021639D0 (en)	2000-10-18	Maurotoxin derivatives